期刊
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
卷 72, 期 2, 页码 304-309出版社
ELSEVIER
DOI: 10.1016/j.ejpb.2008.08.006
关键词
Transdermal iontophoresis; Migraine; Zolmitriptan; In vivo
The objective was to investigate the transdermal delivery kinetics of zolmitriptan from an iontophoretic patch system in Yorkshire swine in vivo. Preliminary in vitro experiments showed that cumulative drug transport during a 6-h current application (0.25 mA cm(-2)) was independent of patch load (263.7 +/- 92.7, 357.2 +/- 85.9, 374.9 +/- 74.3 and 335.9 +/- 27.7 mu g cm(-2) for 7.5, 15, 45 and 90 mg patch loads, respectively; ANOVA. p < 0.05); the steady-state flux was similar to 92 mu g cm(-2) h(-1). The in vivo studies used multistep current profiles to demonstrate (i) rapid drug uptake and (ii) the effect of superposing a bolus input on basal drug levels. In both studies, zolmitriptan was detected in the blood after 2.5 min; drug levels were 7.1 1.7 and 10.4 +/- 3.5 ng ml(-1) at t = 30min in Studies 1 and 2, respectively. In Study 2, increasing current intensity from 0.2 to 1.4 mA (0.05-0.35 mA cm(-2)) at t = 180 min caused zolmitriptan levels to rise from 9.38 +/- 0.93 ng ml(-1) at t = 180 min to 13.57 +/- 1.85 ng ml(-1) at t = 190 min; a similar to 50% increase in 10 min. Extrapolation of these results to humans suggests the feasibility of delivering therapeutic amounts of zolmitriptan at faster rates than those from existing dosage forms. (C) 2008 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据